These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22171470)

  • 1. [Antiviral humanized and human monoclonal antibodies].
    Lashkevich VA
    Vopr Virusol; 2011; 56(5):4-8. PubMed ID: 22171470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus: concerns and control.
    McCarthy CA; Hall CB
    Pediatr Rev; 2003 Sep; 24(9):301-9. PubMed ID: 12949266
    [No Abstract]   [Full Text] [Related]  

  • 3. Respiratory syncytial virus: different criteria for palivizumab use in different areas?
    Mitchell I
    South Med J; 2007 Jul; 100(7):661-2. PubMed ID: 17639741
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies for the prevention and treatment of viral diseases.
    Sawyer LA
    Antiviral Res; 2000 Aug; 47(2):57-77. PubMed ID: 10996394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of respiratory syncytial virus infection with palivizumab.
    Thomas M; Bedford-Russell A; Sharland M
    Monaldi Arch Chest Dis; 2000 Aug; 55(4):333-8. PubMed ID: 11057088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience of palivizumab in prophylaxis of respiratory syncytial viral infection in premature children with bronchopulmonary dysplasia].
    Aliamovskaia GA; Keshinian ES
    Vestn Ross Akad Med Nauk; 2012; (12):30, 32-4. PubMed ID: 23530423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses.
    Zhu Z; Dimitrov AS; Chakraborti S; Dimitrova D; Xiao X; Broder CC; Dimitrov DS
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):57-66. PubMed ID: 16441209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the development and approval of monoclonal antibodies for viral infections.
    Reichert JM
    BioDrugs; 2007; 21(1):1-7. PubMed ID: 17263584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New strategies for control of respiratory syncytial virus infection.
    Nokes JD; Cane PA
    Curr Opin Infect Dis; 2008 Dec; 21(6):639-43. PubMed ID: 18978532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral prophylaxis and treatment (excluding HIV therapy).
    Waugh SM; Pillay D; Carrington D; Carman WF
    J Clin Virol; 2002 Dec; 25(3):241-66. PubMed ID: 12423690
    [No Abstract]   [Full Text] [Related]  

  • 11. A review of cost-effectiveness of palivizumab for respiratory syncytial virus.
    Hussman JM; Li A; Paes B; Lanctôt KL
    Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):553-67. PubMed ID: 23140255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Viral Complications of Pregnancy: Pharmacotherapy to Reduce Vertical Transmission.
    Rogan SC; Beigi RH
    Obstet Gynecol Clin North Am; 2021 Mar; 48(1):53-74. PubMed ID: 33573790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of palivizumab and emerging therapies for respiratory syncytial virus.
    Shadman KA; Wald ER
    Expert Opin Biol Ther; 2011 Nov; 11(11):1455-67. PubMed ID: 21831008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus infections: strategies of prevention.
    Deinhardt F
    Behring Inst Mitt; 1992 Apr; (91):28-37. PubMed ID: 1524569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential for palivizumab interference with commercially available antibody-antigen based respiratory syncytial virus diagnostic assays.
    Deming DJ; Patel N; McCarthy MP; Mishra L; Shapiro AM; Suzich JA
    Pediatr Infect Dis J; 2013 Oct; 32(10):1144-6. PubMed ID: 23584584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of viral infections in stem cell transplant recipients.
    Ljungman P
    Br J Haematol; 2002 Jul; 118(1):44-57. PubMed ID: 12100127
    [No Abstract]   [Full Text] [Related]  

  • 17. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants.
    Blanken MO; Rovers MM; Molenaar JM; Winkler-Seinstra PL; Meijer A; Kimpen JL; Bont L;
    N Engl J Med; 2013 May; 368(19):1791-9. PubMed ID: 23656644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Respiratory syncytial immunoprophylaxis with palivizumab].
    De Halleux V; Lombet J; Rigo J
    Rev Med Liege; 2007; 62(5-6):299-302. PubMed ID: 17725198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against viruses and bacteria: a survey of patents.
    Xiao X; Dimitrov DS
    Recent Pat Antiinfect Drug Discov; 2007 Nov; 2(3):171-7. PubMed ID: 18221173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus prophylaxis in preterm infants: a cost-effectiveness study from Turkey.
    Oncel MY; Mutlu B; Kavurt S; Baş AY; Demirel N; Akyol M; Erdeve O; Dilmen U
    Turk J Pediatr; 2012; 54(4):344-51. PubMed ID: 23692714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.